0126 ECP Resolution
BioCentury & Getty Images

Emerging Company Profile

Resolution: Fighting fibrosis with macrophages

Resolution is bringing macrophage cell therapies into the fibrosis arena

With £26.6 million and clinical data supporting the concept, Resolution is bringing macrophage cell therapies into the fibrosis arena.

Jan 26, 2021 | 9:18 PM GMT

Macrophages are emerging as one of the hottest tools in the fight against cancer, but Resolution is targeting a new application for the cells: attacking fibrosis. 

The Syncona-backed company launched in August with £26.6 million to develop

Read the full 809 word article

How to gain access

Continue reading with a
two-week free trial.